首页 | 本学科首页   官方微博 | 高级检索  
     

曲妥珠单抗在Her-2高表达胃癌治疗中的研究近况
引用本文:章娟,吴洪斌,翟青. 曲妥珠单抗在Her-2高表达胃癌治疗中的研究近况[J]. 中国医院用药评价与分析, 2010, 0(5): 390-393
作者姓名:章娟  吴洪斌  翟青
作者单位:复旦大学附属肿瘤医院药剂科;复旦大学上海医学院肿瘤学系;
摘    要:目的:了解曲妥珠单抗(赫赛汀)在人表皮生长因子受体2(Her-2)高表达胃癌治疗中的研究近况。方法:对近年来曲妥珠单抗(赫赛汀)在Her-2高表达胃癌治疗中研究情况的文献资料进行分析,并对Her-2相关的检测方法进行探讨。结果:曲妥珠单抗(赫赛汀)在体内外能够抑制Her-2高表达胃癌细胞的生长,Ⅱ、Ⅲ期临床试验结果显示它能明显提高Her-2高表达胃癌患者的疗效和生活质量,显著延长生存时间。结论:曲妥珠单抗(赫赛汀)有望成为一种新型的治疗胃癌的生物靶向药物。

关 键 词:曲妥珠单抗  表皮生长因子受体  胃癌

Rcent Progress in Research on Trastuzumab (Herceptin) Against Overexpression of Her-2 in Patients with Gastric Cancer
ZHANG Juan,WU Hong-bin#,ZHAI Qing. Rcent Progress in Research on Trastuzumab (Herceptin) Against Overexpression of Her-2 in Patients with Gastric Cancer[J]. Evaluation and Analysis of Drug-Use in Hospital of China, 2010, 0(5): 390-393
Authors:ZHANG Juan  WU Hong-bin#  ZHAI Qing
Affiliation:ZHANG Juan,WU Hong-bin#,ZHAI Qing (Dept. of Pharmacy,Fudan University Affiliated Tumor Hospital,Department of Oncology,Shanghai Medical College of Fudan University,Shanghai 200032,China)
Abstract:OBJECTIVE: To probe into the recent progress in research on Trastuzumab ( Herceptin) against overexpression of human epidermal growth factor receptor 2 (Her-2) in patients with gastric cancer. METHODS: The pertinent literature in recent years both at home and abroad about Trastuzumab ( Herceptin) against overexpression of Her-2 in patients with gastric cancer was reviewed,and the various testing methods of Her-2 were reviewed. RESULTS: Trastuzumab could inhibit the growth of Her-2 overexpressing cancerous c...
Keywords:Trastuzumab (Herceptin)  Epidermal growth factor receptor  Gastric cancer  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号